Dermatology Genetics Panel
The Dermatology Genetics Panel is an advanced targeted Next-Generation Sequencing (NGS) assay designed to comprehensively profile the genetic spectrum of inherited and acquired dermatological disorders. By evaluating genes governing epidermal integrity, barrier function, pigmentation, and cutaneous appendages (hair, nails, sweat glands), this panel resolves diagnostic ambiguity in genodermatoses, hereditary hair/nail dystrophies, and familial cutaneous malignancies (e.g., melanoma).
Key Features & Advantages
- Definitive Molecular Diagnosis: Deciphers phenotypic overlaps in complex and rare genodermatoses to deliver precise diagnostic classification.
- Cutaneous Cancer Risk Stratification: Identifies germline susceptibility variants for familial melanoma and non-melanoma skin cancers to guide personalized surveillance programs.
- Prognostic & Systemic Insights: Predicts potential extra-cutaneous or systemic organ involvement based on specific causative gene variants.
- Cascade Screening & Family Planning: Establishes precise inheritance patterns (autosomal dominant/recessive, X-linked) to support carrier testing and reproductive counseling.
Dermatology NGS Panel vs. Conventional Skin Biopsy
| Feature | Dermatology NGS Panel (NGS) | Conventional Skin Biopsy (Histopathology) |
| Diagnostic Level | Direct underlying genomic & molecular etiology | Cellular architecture & tissue-level alteration |
| Pre-Symptomatic Detection | Yes (Identifies hereditary cancer & disorder risks early) | No (Detects changes only after physical lesion develops) |
| Familial Risk Mapping | Precise (Identifies mutation inheritance mode) | Limited / None |
| Sample Requirement | Peripheral Blood, Saliva, or Tissue DNA | Invasive Skin Tissue Biopsy Only |
| Therapeutic Management | Genotype-targeted personalized therapies | Symptom-driven topical & systemic options |
Key Applications
- Epidermal Fragility & Keratinization Disorders: Comprehensive panels for Epidermolysis Bullosa (EB), Ichthyosis, and Palmoplantar Keratodermas.
- Pigmentary & Photosensitivity Syndromes: Profiling Xeroderma Pigmentosum (XP), Oculocutaneous Albinism (OCA), and vitiligo susceptibility.
- Hereditary Cutaneous Malignancies: Screening susceptibility loci for Familial Melanoma (CDKN2A, CDK4), Gorlin Syndrome, Cowden Syndrome, and Muir-Torre Syndrome.
- Ectodermal Dysplasias & Appendage Disorders: Genetic characterization of syndromes affecting hair, nail, tooth, and sweat gland development.
The Nucleus Genetics Advantage: Combining ultra-deep NGS coverage designed for dermatogenetics with curated clinical databases and joint curation by medical geneticists and dermatologists, we transform complex cutaneous variants into actionable clinical reports.
Get Information About This Service
Our expert team is ready to answer your questions and offer tailored solutions.
Contact Form →